CHICAGO, June 17, 2014 (GLOBE NEWSWIRE) -- Durata Therapeutics (Nasdaq:DRTX) announced today that members of the executive team will participate in three upcoming investor conferences.
Paul R. Edick, Chief Executive Officer, will participate in the ROTH Resources Corporate Access Day on June 24 in London, England.
Corey Fishman, Chief Operating Officer and Chief Financial Officer, will present at the JMP Healthcare Conference on June 24 at 9:30am EDT in New York, New York.
Mr. Fishman will also participate in the Janney Capital Markets Healthcare Corporate Access Day on June 26 in Boston, Massachusetts.
About Durata Therapeutics, Inc.
Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. For more information about the company, visit www.duratatx.com.
Statements contained in this press release contain forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this press release, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.
CONTACT: Investor Relations and Public Affairs Contact Allison Wey Durata Therapeutics Vice President, Investor Relations and Public Affairs (312) 219-7017 email@example.com
Source:Durata Therapeutics, Inc.